Immune Response to Rotavirus Polypeptides after Vaccination with Heterologous Rotavirus Vaccines (RIT 4237, RRV-1)
|
|
- Edward Sherman
- 5 years ago
- Views:
Transcription
1 J gen Virol (1987), 68, Printed in Great Britain 1993 Key words: rotavirus/vaccine/immune response Immune Response to Rotavirus Polypeptides after Vaccination with Heterologous Rotavirus Vaccines (RIT 4237, RRV-1) By LENNART SVENSSON, 1,2 HOOSHMAND SHESHBERADARAN, 2 TIMO VESIKARI, 3 ERLING NORRBY 2 AND G(}RAN WADELL* 1Department of Virology, National Bacteriological Laboratory, S Stockholm, "-Department of Virology, Karolinska Institute, School of Medicine, S Stockholm, Sweden, 3Department of Clinical Sciences, University of Tampere, SF Tampere, Finland and *Department of Virology, University of Umeh, S Umeh, Sweden (Accepted 30 March 1987) SUMMARY The antibody response to individual rotavirus polypeptides after vaccination with live attenuated heterologous rot,virus vaccines was studied with a radioimmunoprecipitation assay (RIPA) Following vaccination with bovine rotavirus strain RIT 4237 and rhesus monkey rotavirus strain RRV-1, an antibody response was demonstrated mainly against the inner capsid polypeptides VP2 and VP6 and to a lesser extent against VP3/VP4 There was no qualitative difference between the vaccines in the antibody response; both vaccines induced antibodies against the same polypeptides Quantitatively the antibody response to RRV-1 was somewhat stronger All prevaccination sera contained by RIPA low levels of rotavirus antibodies The effect of these antibodies on the 'take' of the vaccines is discussed Heterologous rotaviruses and human-animal rotavirus reassortants have been proposed as candidate vaccines against human rotavii'us diarrhoea (Clark et al, 1986; Kapikian et al, 1985a: Midthun et al, 1985; Vesikari et al, 1983) Two animal rotaviruses are currently under evaluation in clinical trials (Anderson et al, 1986; Kapikian et al, 1985a, b; Vesikari et al, 1983, 1984, 1986a) One of these is strain RIT 4237, an attenuated bovine rotavirus which has been shown to induce cross-protection to rotavirus diarrhoea in young infants in Finland (Vesikari et al, 1984, 1985) The RIT 4237 virus shares group antigens with human rotavirus, but is serotypically distinct (Hoshino et al, 1984) The other major vaccine candidate is a rhesus rotavirus, RRV-1, developed by Kapikian et al (1985a) The RRV-1 virus also shares group antigens with human rotavirus but may have an immunological advantage over the RIT 4237 virus by being immunologically very closely related, if not identical, to human rotavirus serotype 3 (Hoshino et al, 1984) The RRV-1 virus is less attenuated and more immunogenic than RIT 4237 and when used at high doses it causes, in contrast to RIT 4237, significant febrile reactions in children (Vesikari et al, 1986a) So far, there is little information on the protective efficacy of the RRV-1 vaccine, but it may be assumed that, like the bovine rotavirus, the rhesus rotavirus will also induce cross-protection against human rotavirus Little is known about the mechanism of protection against human rotavirus diarrhoea evoked by immunization with heterologous rotaviruses In particular, the role of neutralizing antibodies is unclear In spite of the fact that the RIT 4237 vaccine induces neutralizing antibodies only against the homologous bovine virus and not against human serotypes (Vesikari et al, 1983) it nevertheless conveys protection against human rotavirus diarrhoea Of the two surface polypeptides (VP3 and VP7) involved in virus neutralization (Bastardo et al, 1981 ; Offit et al, 1985; Taniguchi et al, 1985), VP3 has been found to induce neutralizing antibodies against heterotypic rotavirus (Offit et al, 1985; SGM
2 1994 Short communication Taniguchi et al, 1985) However, the role of VP3 in eliciting protection against rotavirusinduced diarrhoea is not yet known, nor is it known to what extent VP3 and VP7 induce an immune response following vaccination Recently, by use of a radioimmunoprecipitation assay (RIPA), we characterized the antibody response to different rotavirus proteins following a natural infection (Svensson et al, 1987) In the present study we have analysed the immune response to individual rotavirus polypeptides following vaccination with the heterologous rotavirus vaccines RIT 4237 and RRV-1 The passage history and preparation of the live attenuated bovine rotavirus vaccine RIT 4237 and the rhesus rotavirus vaccine RRV-1 have previously been reported (Delem et al, 1984; Kapikian et al, 1985a) Sera from children vaccinated with the RIT 4237 and the RRV-1 vaccines were obtained from a comparative trial in Finland (Vesikari et al, 1986a) Briefly, children 6 to 8 months old were given a single oral dose (05 ml) of the RIT 4237 vaccine lot no L1109 at TCIDs0/dose into the back of the mouth The RRV-1 was given orally into the back of the mouth as a single do 10Sto 106 pfu, in 1 ml Serum specimens were collected before vaccination and on day 28 after vaccination Of the 49 paired sera available, twelve serum pairs, six from the recipients of RIT 4237 and six of RRV-1, were selected for analysis in the present study The selection was made on the basis that each of the 12 children had shown evidence of vaccine 'take' by at least one serological test (Vesikari et al, 1986a) Preimmune and convalescent sera from four naturally infected children were kindly provided by Dr I Uhnoo, Uppsala, Sweden Preimmune and convalescent sera were collected 1 to 2 days and 16 to 31 days after the onset of illness, respectively The ages of the four control children with natural rotavirus infection were as follows; child 13, 6 years 3 months; child l 4, 20 months; child 15, 8 years 6 months and child 16, 15 months Two human rotavirus strains, DS-1 (subgroup I, serotype 2) and Wa (subgroup II, serotype 1), previously characterized by Dr R Wyatt (NIH, Bethesda, Md, USA), were obtained from Dr B Tufvesson (Maim/5 Allm~inna Sjukhus, Maim/5, Sweden) The human strains as well as simian rotavirus SA-11 (subgroup I, serotype 3) and the RIT 4237 strain (subgroup I, serotype 6) were plaque-purified twice before use Radiolabelling of intracellular rotavirus polypeptides was performed essentially as previously described (Svensson et al, 1987) Briefly, at 6 h post-infection, the original medium (Eagle's MEM, 5 ~tg/ml trypsin, 8 ~tg/ml actinomycin D) was replaced by methionine-free Eagle's MEM supplemented with 5 ~tg/ml trypsin and 8 ~tg/ml actinomycin D Seven hours after infection the medium was replaced by Eagle's MEM containing one-tenth the normal concentration of methionine, 100 ktci/ml [3SS]methionine, 8 ~tg/ml actinomycin D, 5 ~tg/ml trypsin After 3 h of labelling, cells were scraped off and pelleted by centrifugation for 1 h at g The RIPA and SDS-polyacrylamide gel electrophoresis (SDS-PAGE) are described in detail elsewhere (Svensson et al, 1987) The separation SDS gel (14 cm long) consisted of 11 or 9~ acrylamide, 029~ N,N'-methylenebisacrylamide Trypsin (Type IX) and actinomycin D were purchased from Sigma The ~4C-methylated protein markers and [3SS]methionine were purchased from New England Nuclear Typical profiles of 35S_labelled polypeptides of DS-1 virus- and mock-infected cells are shown in Fig 1 The mol wt of the virus-coded proteins were calculated and compared to previously reported data (Oflit et al, 1983; Svensson et al, 1987) As reported previously (Svensson et al, 1987) NS1 and VP5 could not be identified in infected cell lysates (Fig 1) These two proteins could, however, be identified after immunoprecipitation (Fig 2) As reported previously (Svensson et al, 1987) VP3 and VP4 of the DS-1 strain could not be clearly separated and therefore immunoprecipitates in the mol wt region are referred to as VP3/VP4 All sera were tested by RIPA in dilutions ranging from 1 : 10 to 1 : against lysates of cells infected by SA-11, DS-1, WA or RIT 4237, and against mock-infected cells To avoid variability in immunoprecipitation levels, all sera were simultaneously tested on the same batch of radiolabelled cell lysate for each virus strain The immune response patterns exhibited by the sera were similar regardless of the virus antigen used; therefore only data obtained with the DS- 1 strain are presented
3 Short communication ,,-~t 4 vpl VP2 VP3 VP4 i~ VP6 O 41 VP7 41 NS, NS 3 4 vp8 41VP9 O Fig 1 SDS-PAGE of [3sS]methionine-labelled rotavirus polypeptides synthesized in the presence of 8 ~tg/ml actinomycin D Lane 1, mock-infected cells Lane 2, ~4C-methylated mol wt markers, from the top: phosphorylase b (97000), bovine serum albumin (69000), ovalbumin (46000), carbonic anhydrase (30000), lactoglobulin (18000) Lane 3, DS-1 rotavirus-infected cells Note that VP5 and NS~ with expected mol wt of and 56000, respectively, cannot be recognized None of the sera reacted at 1:10 dilution with mock-infected cells Variation in the number of polypeptides immunoprecipitated with sera from vaccinated and naturally infected children were observed (Fig 2) It appears that the pre-vaccination sera from all of the vaccinated children contained antibodies against VP2 and VP6 In some cases a very weak precipitation of VP3/VP4 could be seen although the titre levels varied between the sera The antibody titres were low Preimmune sera of two of the four naturally infected children (children 15 and 16) also contained rotavirus protein-specific antibodies as shown by RIPA The most pronounced precipitates were again obtained with VP2 and VP6, but in addition VP3/VP4 were also immunoprecipitated Two preimmune sera (children 13 and 14) showed no reaction by RIPA with any rotavirus polypeptides The immune response following vaccination with either RIT 4237 or RRV-1 appeared to b'e weaker than that after a natural rotavirus infection The strongest immune response in the vaccinees was directed against VP6 Titration experiments showed that children who received RRV-1 vaccine had antibody titres between 5000 and in their convalescent sera against VP6 (the polypeptide inducing the strongest immune response) while the comparable antibody titres for RIT 4237 vaccinees were 500 to 5000 Thus RRV-1 appeared to be slightly more immunogenic than the RIT 4237 vaccine A comparison of the immune responses to various DS- 1 proteins in pre- and post-vaccination sera is shown in Fig 3 Both vaccines accelerated the antibody response to VP2 and VP6 and to a lesser degree to VP3/VP4, None of the vaccinated
4 Short communication 1996 (a) M ~J -~-- 97 ~ "~--46 (b) M ~ d l D ~v--vp1 -~--VP3 "~'--VP4 ~----VP5 "q~--nsj ~s---vp6 ~---VP7,v--NS2 ~'-NS 3 Fig 2 Immunoprecipitation of[3ss]methionine-labetled human rotavirus (DS-1) polypeptideswith (a) preimmune and (b) convalescent sera from rotavirus-vaccinated (lanes 1 to 12) or naturally infected children (lanes 13 to 16) All sera were tested at 1:10 dilution Children 1 to 6 were vaccinated with RRV-1 and 7 to 12 were vaccinated with RIT 4237 Mol wt markers (M) were the same as in Fig 1 Note that lactoglobulin (18000) is not separated, nor are VP7, NS2 or NS 3 well separated, due to the use of a lower polyacrylamide concentration (9%) children developed detectable antibodies against VP1, a core protein, or against VP5, VP7, VP8 or VP9 N o reactivity was seen with the three non-structural proteins (NS1 to NS3) In contrast, two naturally infected children (children 13 and 14) seronegative in their p r e i m m u n e serum, developed antibodies to VP2, VP3/VP4, VP6 and to NS2/NS3 The present study was designed to analyse by use of a R I P A the i m m u n e response to h u m a n rotavirus proteins acquired by oral vaccination with the two current heterologous rotavirus vaccine candidates, R I T 4237 and RRV-1 The paired sera were selected on the basis of so called vaccine ' t a k e ' from a recently published vaccine trial (Vesikari et al, 1986a) All the p r e i m m u n e sera tested were found by R I P A to have rotavirus antibodies These sera were shown in the vaccine trial to be negative by complement fixation and ELISA If the pre-vaccination antibodies in these children were due to a previous rotavirus infection and were not maternally acquired, the vaccine-induced responses might be regarded as booster reactions However, the relatively low level immune response seen after vaccination c o m p a r e d to a natural infection
5 Short communication 1997 (a) (b) VP2 ~ ~ VP2 ~ VP6 ~ ~,~ Fig 3 Comparison of immune responses (by RIPA) to various DS-1 polypeptides in pre- and postvaccination sera and titrations of post-vaccination sera (a) Child 1 ; recipient of RRV-1 vaccine; pre 1:50 (lane 1), post 1 : 100 (lane 2), 1:500 (lane 3), 1 : 1000 (lane 4), 1 : 5000 (lane 5), 1 : (lane 6) (b) Child 7; recipient of RIT 4237 vaccine; pre 1 : 50 (lane 1), post 1 : 100 (lane 2), 1 : 500 (lane 3), 1 : 1000 (lane 4), 1:5000 (lane 5), 1:10000 (lane 6) rather suggests that the pre-existing serum antibodies would be of maternal origin The presence of such antibodies might still interfere with the 'take' of the RIT 4237 and RRV-1 vaccines, as shown previously with other serological tests (Vesikari et al, 1986a, b) The role pre-existing antibodies play in the 'take' of attenuated rotavirus vaccines remains to be elucidated The RRV-1 vaccine was found to be more immunogenic than the RIT vaccine but there was no qualitative difference in the antibody pattern Despite the close serological relation to human rotavirus serotype 3 (Hoshino et al, 1984) the RRV-1 vaccine failed to induce detectable antibodies against the outer viral capsid proteins Although the RIT 4237 vaccine does not appear to induce VP7 antibodies or any significant neutralizing antibody response against human rotaviruses (Vesikari et al, 1983), it protects against rotavirus diarrhoea (Vesikari et al, 1984, 1985) It has been shown previously that neutralizing antibodies against the homologous vaccine virus are elicited by both RRV-1 (Kapikian et al, 1985a; Vesikari et al, 1986a) and RIT 4237 vaccines (Vesikari et al, 1986a) All sera of vaccinees analysed in the present study have previously been studied for neutralizing antibodies against homologous virus: all six RRV-1 recipients had a greater than fourfold antibody titre, whereas the number of RIT 4237 vaccinees with an antibody titre rise greater than fourfold was three of six (Vesikari et al, 1986a; unpublished data) The post-vaccination immune responses were found by the RIPA test to be directed mainly to VP2, VP6 and to a lesser extent to VP3/VP4 The failure of the rotavirus vaccines to induce detectable antibody responses to VP7, the major polypeptide involved in virus neutralization (Offit et al, 1985; Taniguchi et al, 1985), is surprising Lack of detectable antibody response to the glycosylated VP7 was also seen in the two naturally infected children without pre-existing immunity Neither child had any VP7-specific antibodies at the time of serum collection (child 13, day 31; child 14, day 16), although both had neutralizing antibodies (low titres) against serotype 2 and 3, respectively (Svensson et al, 1987) However, antibodies to VP3 have previously been shown to induce heterologous protection in vivo (Offit et al, 1985) and such antibodies may also be involved in protection of the vaccinees The presence of VP3 antibodies in the vaccine sera could not however, be clearly identified in this study, due to comigration of the VP3 and VP4 polypeptides
6 1998 Short communication The RIPA does not detect antibodies of immunoglobulin classes other than IgG and it is possible that, at 28 days post-vaccination, the newly induced neutralizing antibodies are to some extent of the IgM class The absence of antibodies directed to non-structural proteins probably reflects restricted replication of the vaccine viruses in the enterocytes The sera from naturally infected children 15 and 16 show that, upon re-infection, the primary immune response is accelerated and expanded, not only to the originally detected polypeptides but also to new polypeptides including non-structural proteins It has been suggested that the heterologous candidate rotavirus vaccines could be improved by using animal-human reassortant rotaviruses containing the glycosylated VP7 from human strains It is doubtful whether such viruses would induce a better antibody response than the original heterologous viruses In fact, administration of a reassortant bovine rotavirus vaccine containing the gene coding for VP7 of a human strain to adult human volunteers has been disappointing (Clark et al, 1986) However, if reassortant rotaviruses are to be used, not only VP7 but also the role VP3 plays in virulence (Offit et al, 1986) and in induction of heterotypic immunity (Offit et al, 1985; Taniguchi et al, 1985) has to be considered when designing reassortant vaccines The induction of rotavirus-specific IgG and IgM antibodies is a valuable marker for evaluation of the 'take' of a vaccine and for analysing the immune response Intestinal IgA may play an important role in the resistance to rotavirus-induced diarrhoea Further studies are in progress to clarify to what extent attenuated rotavirus vaccines stimulate rotavirus-specific IgA and to analyse what proteins stimulate this immune response We thank Dr Monica Grandien and Dr Albert Z Kapikian for valuable discussions and Dr Ingrid Uhnoo for the sera from the naturally infected children REFERENCES ANDERSON, E L, BELSCHE, R B, BARTRAM, J, CROOKSHANKS-NEWMAN, F, CHANOCK, R M & KAPIKIAN, A Z (1986) Evaluation of rhesus rotavirus vaccine (MMU 18006) in infants and young children Journal oflnfectious Diseases 153, BASTARDO, J W, McKIMM-BRESCHKIN, J L, SONZA, S, MERCER, L D & HOLMES, L (1981) Preparation and characterization of antisera to electrophoretically purified SA-11 virus polypeptides Infection and Immunity 34, 641~547 CLARK, H F, OFFIT, P A, DOLAN, K T, TEZZA, A, GOGALIN, K, TWIST, E M & PLOTKIN, S A (1986) Response of adult human volunteers to oral administration of bovine and bovine human reassortant rotaviruses Vaccine 4, DELEM, A, LOBMANN, M & ZYGRAICH, N (1984) A bovine rotavirus developed as a candidate vaccine for use in humans Journal of Biological Standardization 12, 443~g45 nosm~o, v, WYATT, R G, GREENBERG, H B, FLORES, J & KAPIKIAN, A Z (1984) Serotypic similarity and diversity of rotaviruses of mammalian and avian origin as studied by plaque-reduction neutralization Journal of Infectious Diseases 149, KAPIKIAN, A Z, MIDTHUN, K, HOSHINO, Y, FLORES, J, WYATT, R G, GLASS, R I, ASKAA, J, NAKAGOMI, O, NAKAGOMI, T, CHANOCK, R M, LEVINE, M M, CLEMENTS, M L, DOL1N, R, WRIGHT, P F, BELSHE, R B, ANDERSON, E L & POTASH, L (1985a) Rhesus rotavirns: a candidate vaccine for prevention of human rotavirus disease In Vaccines "85: Molecular and Chemical Basis of Resistance to Viral, Bacterial and Parasitic Diseases, pp Edited by R A Lerner, R M Chanock & F Brown New York: Cold Spring Harbor Laboratory KAPIKIAN, A Z, HOSHINO, Y, FLORES, J, MIDTHUN, K, GLASS, R L, NAKAGOMI, O, NAKAGOMI, T, CHANOCK, R M, POTASH, L, LEVINE, M M, DOLIN, R, WRIGHT, P F, BELSHE, R E, ANDERSON, E L, VESIKARI, T, GOTHEFORS, L, WADELL, G & PEREZ-SCHAEL, I (1985b) Alternative approaches to the development of a rotavirus vaccine Nobel Conference 11 In Development of Vaccines and Drugs against Diarrhoea, pp Edited by J Holmgren, A Lindberg & R M611by Lund: Studentlitteratur; Bromtey: ChartweU-Bratt MIDTHUN, K,, GREENBERG, H B, HOSHINO, Y, KAPIKIAN, A Z, WYATT, R G & CHANOCK, R M (1985) Reassortant rotaviruses as potential live rotavirus vaccine candidates Journal of Virology 53, OFFIT, P A, CLARK, H F & PLOTKIN, S A (1983) Response of mice to rotavirus of bovine or primate origin assessed by radioimmunoassay, radioimmunoprecipitation and plaque reduction neutralization Infection and Immunity 42, OFFIT, P A, SHAW, R D & GREENBERG, H B 0985) Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to surface proteins vp3 and vp7 Journal of Virology 58, OFFIT, P A, BLAVAT, G, GREENBERG, H B & CLARK, H F (1986) Molecular basis of rotavirns virulence : role of gene segment 4 Journal of Virology 57, 46-49
7 Short communication 1999 SVENSSON, L, SHESHBERADARAN, H, VENE, S, NORRBY, E, GRANDIEN, M & WADELL, G (1987) Serum antibody responses to individual viral polypeptides in human rotavirus infections Journal of General Virology" 68, TANIGUCHI, K, URASAWA, S & URASAWA, T (1985) Preparation and characterization of neutralizing monoclonal antibodies with different reactivity patterns to human rotaviruses Journal of General Virology 66, VESIKARI, T, ISOLAURI, E, DELEM, A, D'HONDT, E, ANDRE, F E & ZISSIS, G (1983) Immunogenicity and safety of live oral attenuated bovine rotavirus vaccine strain RIT 4237 in adults and young children Lancet ii, VESIKARI, T, ISOLAURI, E, D'HONDT, E, DELEM, A, ANDRE, F E & ZISSIS, G (1984) Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccine Lancet i, VESIKARI, T, ISOLAURI, E, DELEM, A, D'HONDT, E, ANDRI~, F E, BEARDS, G M & FLEWETF, T H (1985) Clinical efficacy of the RIT 4237 live attenuated bovine rotavirus vaccine in infants vaccinated before a rotavirus epidemic Journal of Pediatrics 107, VESIKARI, T, KAPIKIAN, A Z, DELEM, A & ZlSSlS, G (1986a) A comparative trial of rhesus monkey (RRV-1) and bovine (RIT 4237) oral rotavirus vaccines in young children Journal oflnfectious Diseases 153, VESIKARI, T, RUUSKA, T, BOGAERTS, H, DELEM, A & ANDRI~, F E (1986b) Dose response study of RIT 4237 oral rotavirus vaccine in breastfed and formula-fed infants Pediatric Infectious Diseases 4, (Received 29 December 1986)
Parkville, Victoria, 3052, Australia. protein VP4, and the letter G is used to denote the glycoprotein
JOURNAL OF CLINICAL MICROBIOLOGY, Feb. 1993, p. 377-385 0095-1137/93/020377-09$02.00/0 Vol. 31, No. 2 Analysis of Homotypic and Heterotypic Serum Immune Responses to Rotavirus Proteins Following Primary
More informationNeutralization Epitopes on VP4 and VP7 after Rotavirus Infection or Vaccination
JOURNAL OF CLINICAL MICROBIOLOGY, Mar. 1991, p. 483-487 0095-1137/91/030483-05$02.00/0 Copyright X3 1991, American Society for Microbiology Vol. 29, No. 3 Antibody Response to Serotype-Specific and Cross-Reactive
More informationClinical Studies of a Quadrivalent Rotavirus Vaccine in Venezuelan Infants
JOURNAL OF CLINICAL MICROBIOLOGY, Mar. 1990, p. 553-558 0095-1137/90/030553-06$02.00/0 Copyright 1990, American Society for Microbiology Vol. 28, No. 3 Clinical Studies of a Quadrivalent Rotavirus Vaccine
More informationtant human rotavirus serotypes are represented by the
JOURNAL OF CLINICAL MICROBIOLOGY, Dec. 1989, p. 2799-2804 0095-1137/89/122799-06$02.00/0 Copyright 1989, American Society for Microbiology Vol. 27, No. 12 Comparison of Immunoglobulin A (IgA), IgG, and
More informationReactogenicity and Immunogenicity of a High-Titer Rhesus
JOURNAL OF CLINICAL MICROBIOLOGY, Sept. 1993, p. 2439-2445 Vol. 31, No. 9 0095-1137/93/092439-07$02.00/0 Copyright 1993, American Society for Microbiology Reactogenicity and Immunogenicity of a High-Titer
More informationRotavirus Isolate W161 Representing a Presumptive New Human Serotype
JOURNAL OF CLINICAL MICROBIOLOGY, Sept. 1987, p. 1757-1762 0095-1137/87/091757-06$02.00/0 Copyright C 1987, American Society for Microbiology Vol. 25, No. 9 Rotavirus Isolate W161 Representing a Presumptive
More informationof canine rotavirus (strains A79-10 and LSU 79C-36) and with newly defined third (14) and fourth (15) human rotavirus serotypes.
INFECTION AND IMMUNITY, JUlY 1983, p. 169-173 0019-9567/83/070169-05$02.00/0 Copyright 1983, American Society for Microbiology Vol. 41, No. 1 Serological Comparison of Canine Rotavirus with Various Simian
More informationAnalysis of Host Range Restriction Determinants in the Rabbit Model: Comparison of Homologous and Heterologous Rotavirus Infections
JOURNAL OF VIROLOGY, Mar. 1998, p. 2341 2351 Vol. 72, No. 3 0022-538X/98/$04.00 0 Copyright 1998, American Society for Microbiology Analysis of Host Range Restriction Determinants in the Rabbit Model:
More informationEffect of Mutation in Immunodominant Neutralization Epitopes on the Antigenicity of Rotavirus SA-11
J. gen. Virol. (1985), 66, 2375-2381. Printed in Great Britain 2375 Key words: rotaviruses/antigenieity/antiserum selection Effect of Mutation in Immunodominant Neutralization Epitopes on the Antigenicity
More informationIn Vitro Cultivation of Human Rotavirus in MA 104 Cells
Acute Diarrhea: Its Nutritional Consequences in Children, edited by J. A. Bellanti. Nestle, Vevey/Raven Press, New York 1983. ETIOLOGIC AGENTS OF ACUTE DIARRHEA In Vitro Cultivation of Human Rotavirus
More informationAntigenic relationships among human rotaviruses as determined by
Proc. Nati. Acad. Sci. USA Vol. 87, pp. 7155-7159, September 1990 Medical Sciences Antigenic relationships among human rotaviruses as determined by outer capsid protein VP4 (rotavirus VP4 expression/rotavirus
More informationVaccine Research Center, University of Tampere Medical School, Tampere, Finland; 2 Wyeth Vaccine Research, Pearl River, New York; 3
MAJOR ARTICLE Safety, Efficacy, and Immunogenicity of 2 Doses of Bovine-Human (UK) and Rhesus Rhesus-Human Rotavirus Reassortant Tetravalent s in Finnish Children Timo Vesikari, 1 Aino V. Karvonen, 1 Jukka
More informationRotavirus Vaccines: an Overview
CLINICAL MICROBIOLOGY REVIEWS, July 1996, p. 423 434 Vol. 9, No. 3 0893-8512/96/$04.00 0 Copyright 1996, American Society for Microbiology Rotavirus Vaccines: an Overview KAREN MIDTHUN 1 * AND ALBERT Z.
More informationProduction of Reassortant Viruses Containing Human Rotavirus VP4 and SA11 VP7 for Measuring Neutralizing Antibody following Natural Infection
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, Sept. 1997, p. 509 514 Vol. 4, No. 5 1071-412X/97/$04.00 0 Copyright 1997, American Society for Microbiology Production of Reassortant Viruses Containing
More informationDevelopment of Neutralizing Antibodies and Group A Common Antibodies against Natural Infections with Human Rotavirus
JOURNAL OF CLINICAL MICROBIOLOGY, Aug 1988, p 1506-1512 95-1137/88/081506-07$02/0 Copyright C 1988, American Society for Microbiology Vol 26, No 8 Development of Neutralizing Antibodies and Group A Common
More informationLongitudinal Studies of Neutralizing Antibody Responses to Rotavirus in Stools and Sera of Children following Severe Rotavirus Gastroenteritis
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, Nov. 1998, p. 897 901 Vol. 5, No. 6 1071-412X/98/$04.00 0 Copyright 1998, American Society for Microbiology. All Rights Reserved. Longitudinal Studies of
More informationIdentification of Two Subtypes of Serotype 4 Human Rotavirus by
JOURNAL OF CLINICAL MICROBIOLOGY, JUlY 1988, P. 1388-1392 Vol. 26, No. 7 0095-1137/88/071388-05$02.00/0 Copyright 1988, American Society for Microbiology Identification of Two Subtypes of Serotype 4 Human
More informationSerotype between Bovine Rotavirus Strains
JOURNAL OF CLINICAL MICROBIOLOGY, Feb. 1993, p. 354-358 0095-1137/93/020354-05$02.00/0 Copyright X 1993, American Society for Microbiology Vol. 31, No. 2 Two-Way Cross-Neutralization Mediated by a Shared
More informationSerological Analysis of the Subgroup Protein of Rotavirus, Using Monoclonal Antibodies
INFECTION AND IMMUNITY, Jan. 1983, p. 91-99 Vol. 39, No. 1 0019-9567/83/010091-09$02.00/0 Copyright C 1983, American Society for Microbiology Serological Analysis of the Subgroup Protein of Rotavirus,
More informationAstrovirus-associated gastroenteritis in children
Journal of Clinical Pathology, 1978, 31, 939-943 Astrovirus-associated gastroenteritis in children C. R. ASHLEY, E. 0. CAUL, AND W. K. PAVER1 From the Public Health Laboratory, Myrtle Road, Bristol BS2
More informationnot falling into either family are likely to be of animal origin (17). Recently, two subgroup I HRV strains with a long RNA
JOURNAL OF CLINICAL MICROBIOLOGY, June 1990, p. 1342-1347 0095-1137/90/061342-06$02.00/0 Copyright 1990, American Society for Microbiology Vol. 28, No. 6 Serotype 3 Human Rotavirus Strains with Subgroup
More informationAntibodies. of rotavirus was recognized in 252 (36.1%) of them by. employing a confirmatory ELISA which utilizes goat preimmune
JOURNAL OF CLINICAL MICROBIOLOGY, Apr. 1984, p. 516-52 95-1137/84/4516-5$2./ Copyright 1984, American Society for Microbiology Vol. 19, No. 4 Relative Frequency of Rotavirus Subgroups 1 and 2 in Venezuelan
More informationBovine Rotavirus Serotypes and Their Significance for Immunization
JOURNAL OF CLINICAL MICROBIOLOGY, Sept. 1984, p. 342-346 Vol. 20, No. 3 0095-1137/84/090342-05$02.00/0 Copyright (C 1984, American Society for Microbiology Bovine Rotavirus Serotypes and Their Significance
More informationAntigenic and biochemical characterization of bovine rotavirus V1005, a new member of rotavirus serotype 10
Journal of General Virology (1990), 71, 2625-2630, Printed in Great Britain 2625 Antigenic and biochemical characterization of bovine rotavirus V1005, a new member of rotavirus serotype 10 Harald Briissow,
More informationDiversity of Rotavirus Serotypes in Mexican Infants with Gastroenteritis
JOURNAL OF CLINICAL MICROBIOLOGY, June 1990, p. 1114-1119 0095-1137/90/061114-06$02.00/0 Copyright 1990, American Society for Microbiology Vol. 28, No. 6 Diversity of Rotavirus Serotypes in Mexican Infants
More informationMurine Rotavirus Genes Encoding Outer Capsid Proteins VP4 and VP7 Are Not Major Determinants of Host Range Restriction and Virulence
JOURNAL OF VIROLOGY, May 1993, p. 2448-2455 0022-538X/93/052448-08$02.00/0 Copyright ) 1993, American Society for Microbiology Vol. 67, No. 5 Murine Rotavirus Genes Encoding Outer Capsid Proteins VP4 and
More informationPalo Alto, California rhea in suckling mice was about 105 to 106 times greater than
JOURNAL OF VIROLOGY, Dec. 1994, p. 7766-7773 Vol. 68, No. 12 0022-538X/94/$04.00+0 Copyright 1994, American Society for Microbiology Comparison of Mucosal and Systemic Humoral Immune Responses and Subsequent
More informationHuman-Rhesus Reassortant Rotavirus Vaccines: Safety and Immunogenicity in Adults, Infants, and Children
THE JOURNAL OF INFECTIOUS DISEASES VOL. 158. NO.6. DECEMBER 1988 1988 by The University of Chicago. All rights reserved. 0022-1899/88/5806-0009$01.00 Human-Rhesus Reassortant Rotavirus Vaccines: Safety
More informationDevelopment of a VP6 subunit rotavirus vaccine A dual role of VP6 as a vaccine antigen and an adjuvant
30 August 2018, Minsk 13TH INTERNATIONAL ROTAVIRUS SYMPOSIUM Development of a VP6 subunit rotavirus vaccine A dual role of VP6 as a vaccine antigen and an adjuvant Dr. Vesna Blazevic Head of Laboratory
More informationNew and Underused Vaccines, Rotavirus
New and Underused Vaccines, Rotavirus George Armah Noguchi Memorial Institute for Medical research University of Ghana 10th Annual African Vaccinology Course (VACFA) Cape town, South Africa 10 th to 14
More informationFour-Year Study of Rotavirus Electropherotypes from Cases of Infantile Diarrhea in Rome
JOURNAL OF CLINICAL MICROBIOLOGY, JUlY 1989, P. 1522-1526 0095-1137/89/071522-05$02.00/0 Copyright 1989, American Society for Microbiology Vol. 27, No. 7 Four-Year Study of Rotavirus Electropherotypes
More informationPrevalence of Neutralizing Antibodies against Different Rotavirus Serotypes in Children with Severe Rotavirus-Induced Diarrhea and Their Mothers
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, Jan. 2004, p. 186 194 Vol. 11, No. 1 1071-412X/04/$08.00 0 DOI: 10.1128/CDLI.11.1.186 194.2004 Copyright 2004, American Society for Microbiology. All Rights
More informationVP4-Specific Intestinal Antibody Response to Rotavirus in a Murine Model of Heterotypic Infection
JOURNAL OF VIROLOGY, June 1991, p. 3052-3059 0022-538X/91/063052-08$02.00/0 Copyright 1991, American Society for Microbiology Vol. 65, No. 6 VP4-Specific Intestinal Antibody Response to Rotavirus in a
More informationComparison of Serum and Mucosal Antibody Responses Following
JOURNAL OF CLINICAL MICROBIOLOGY, Apr. 1988, p. 732-738 0095-1137/88/040732-07$02.00/0 Copyright 1988, American Society for Microbiology Vol. 26, No. 4 Comparison of Serum and Mucosal Antibody Responses
More informationThis PDF is available for free download from a site hosted by Medknow Publications
252 Indian Journal of Medical Microbiology, (2006) 24 (4):252-7 Review Article ROTAVIRUS VACCINES G Kang Abstract Rotavirus, the most common cause of severe diarrhea and a leading cause of mortality in
More informationDefinition of Human Rotavirus Serotypes by Plaque Reduction Assay
INFECTION AND IMMUNITY, July 1982, p. 110-115 Vol. 37, No. 1 0019-9567/82/070110-06$02.00/0 Definition of Human Rotavirus Serotypes by Plaque Reduction Assay RICHARD G. WYATT,* HARRY B. GREENBERG, WALTER
More informationCompetition Binding Assay
JOURNAL OF CLINICAL MICROBIOLOGY, Mar. 1992, p. 74-711 95-1137/92/374-8$2./ Copyright 1992, American Society for Microbiology Vol. 3, No. 3 Comparisons of Rotavirus VP7-Typing Monoclonal Antibodies by
More informationAstrovirus associated gastroenteritis in a children's ward
J. clin. Path., 1977, 30, 948-952 Astrovirus associated gastroenteritis in a children's ward J. B. KURTZ, T. W. LEE, AND D. PICKERING From the Virology and Public Health Laboratory, Churchill Hospital,
More informationCross-neutralizing Antibodies Induced by Single Serotype Vaccination of Cows with Rotavirus
J. gen. Virol. (1988), 69, 1647-1658. Printed in Great Britain 1647 Key words: rotavirus/vaccination/cows, passive immunity Cross-neutralizing Antibodies Induced by Single Serotype Vaccination of Cows
More informationAntigenic Variation between Human Respiratory Syncytial Virus Isolates
J. gen. Virol. (1986), 67, 863-870. Printed in Great Britain 863 Key words: RS virus/antigenic variation/phosphoprotein Antigenic Variation between Human Respiratory Syncytial Virus Isolates By H. B. GIMENEZ,*
More informationSubunit Rotavirus Vaccine Administered Parenterally to Rabbits Induces Active Protective Immunity
JOURNAL OF VIROLOGY, Nov. 1998, p. 9233 9246 Vol. 72, No. 11 0022-538X/98/$04.00 0 Copyright 1998, American Society for Microbiology. All Rights Reserved. Subunit Rotavirus Vaccine Administered Parenterally
More informationSubgroup Characteristics of Respiratory Syncytial Virus Strains
JOURNAL OF CLINICAL MICROBIOLOGY, Aug. 1987, p. 1535-1539 0095-1137/87/081535-05$02.00/0 Copyright C 1987, American Society for Microbiology Vol. 25, No. 8 Subgroup Characteristics of Respiratory Syncytial
More informationRotavirus vaccines and vaccination in Latin America
Rotavirus vaccines and vaccination in Latin America Alexandre C. Linhares 1 and Joseph S. Bresee 2 ABSTRACT Worldwide, rotaviruses account for more than 125 million cases of infantile gastroenteritis and
More informationStructural Differences between Subtype A and B Strains of Respiratory Syncytial Virus
J. gen. Virol. (1986), 67, 2721-2729. Printed in Great Britain 2721 Key words: RS virus~antigenic variation~structural polypeptides Structural Differences between Subtype A and B Strains of Respiratory
More informationNeutralization Epitopes on Poliovirus Type 3 Particles: an Analysis Using Monoclonal Antibodies
J.-gen. Virol. (1984), 65, 197-201. Printed in Great Britain 197 Key words: poliovirus type 3/monoclonal Abs/neutralization/immunoblot Neutralization Epitopes on Poliovirus Type 3 Particles: an Analysis
More informationVIRAL AGENTS CAUSING GASTROENTERITIS
VIRAL AGENTS CAUSING GASTROENTERITIS VIRAL AGENTS CAUSING GASTROENTERITIS Pathogens discussed in our lectures 1. Rotavirus 2. Enteric adenoviruses 3. Caliciviruses 4. Astroviruses 5. Toroviruses Viruses
More informationHeterotypic Protection and Induction of a Broad Heterotypic Neutralization Response by Rotavirus-Like Particles
JOURNAL OF VIROLOGY, June 1999, p. 4813 4822 Vol. 73, No. 6 0022-538X/99/$04.00 0 Copyright 1999, American Society for Microbiology. All Rights Reserved. Heterotypic Protection and Induction of a Broad
More informationIsolation and Characterization of Two Group A Rotaviruses with Unusual Genome Profiles
J. gen. ViroL (1987), 68, 653-660. Printed in Great Britain Key words: rotavirus/bovine/genome profile 653 Isolation and Characterization of Two Group A Rotaviruses with Unusual Genome Profiles By D. H.
More informationReceived 10 November 1997/Returned for modification 6 January 1998/Accepted 23 February 1998
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, May 1998, p. 328 334 Vol. 5, No. 3 1071-412X/98/$04.00 0 Copyright 1998, American Society for Microbiology Serotype Specificity of the Neutralizing-Antibody
More informationNucleic Acid from Stool Specimens
JOURNAL OF CLINICAL MICROBIOLOGY, Feb. 1990, p. 276-282 0095-1137/90/020276-07$02.00/0 Copyright 1990, American Society for Microbiology Vol. 28, No. 2 Polymerase Chain Reaction Amplification and Typing
More informationRoger I. Glass, M.D., Ph.D. Fogarty International Center, NIH Viral Gastroenteritis Unit, CDC
Roger I. Glass, M.D., Ph.D. Fogarty International Center, NIH Viral Gastroenteritis Unit, CDC International Rotavirus Symposia- A 30 year history 1-4. 1984, 1986, 1989, 1991 NIH Bethesda, MD USA 5. 1995
More information... Department of Molecular Virology & Microbiology, Baylor College of Medicine, One Baylor Plaza, Mailstop BCM-385, Houston, TX 77030, USA 2
Journal of General Virology (2000), 81, 1237 1249. Printed in Great Britain... Simian rhesus rotavirus is a unique heterologous (non-lapine) rotavirus strain capable of productive replication and horizontal
More information!!!!!! *+*,+-./+,.- 0+! 12! February 2005
!!!!!! "#!"#! $%&'(() *+*,+-./+,.- 0+! 12! February 2005 Disclaimer: This publication contains the collective views of an international group of experts 1 Summary WHO develops international technical specifications
More informationT Vesikari 1, J Joensuu 1, M Baer 2,HKäyhty 4, R-M Ölander 4, H Sormunen 4, A Miettinen 3, RL Ward 5 and T Guillot 6
Acta Pñdiatr 88: 513±20. 1999 Concurrent administration of rhesus rotavirus tetravalent (RRV-TV) vaccine with pentavalent diphtheria pertussis tetanus Haemophilus influenzae b-inactivated polio and hepatitis
More informationExperience of Pentavalent Human-bovine Reassortant Rotavirus Vaccine Among Healthy Infants in Taiwan
ORIGINAL ARTICLE Experience of Pentavalent Human-bovine Reassortant Rotavirus Vaccine Among Healthy Infants in Taiwan Chien-Chih Chang, 1 Mei-Hwei Chang, 1 * Tzou-Yen Lin, 2 Hong-Chang Lee, 3 Wu-Shiun
More informationInfluence of Breast-Feeding and Oral Poliovirus Vaccine on the Immunogenicity and Efficacy of Rotavirus Vaccines
5107 Influence of Breast-Feeding and Oral Poliovirus Vaccine on the Immunogenicity and Efficacy of Rotavirus Vaccines Margaret B. Rennels Division ofinfectious Diseases and Tropical Pediatrics, Department
More informationDiarrheal Response of Gnotobiotic Pigs after Fetal Infection and Neonatal Challenge with Homologous and Heterologous Human Rotavirus Strains
JOURNAL OF VIROLOGY, Dec. 1986, p. 1107-1112 0022-538X/86/121107-06$02.00/0 Copyright C) 1986, American Society for Microbiology Vol. 60, No. 3 Diarrheal Response of Gnotobiotic Pigs after Fetal Infection
More informationHuman Rotavirus Studies in Volunteers: Determination of Infectious Dose and Serological Response to Infection
THE JOURNAL OF INFECTIOUS DISEASES VOL. 154, NO.5. NOVEMBER 1986 1986 by The University of Chicago. All rights reserved. 0022-1899/86/5405-0015$01.00 Human Rotavirus Studies in Volunteers: Determination
More informationNational Institute of Virology
National Institute of Virology Rotavirus 1. Epidemiological studies on rotaviruses 83 Pediatric cases 83 Adolescent and adult cases 84 Rotaviral antibodies present in Indian mothers 84 Rotavirus symptomatic/
More informationComparison of Enzyme Immunoassay, PCR, and Type-Specific cdna Probe Techniques for Identification of Group A Rotavirus Gene 4 Types (P types)
JOURNAL OF CLINICAL MICROBIOLOGY, Dec. 1997, p. 3104 3108 Vol. 35, No. 12 0095-1137/97/$04.00 0 Copyright 1997, American Society for Microbiology Comparison of Enzyme Immunoassay, PCR, and Type-Specific
More informationImportance of Rotavirus and Adenovirus Types 40 and 41 in Acute Gastroenteritis in Korean Children
JOURNAL OF CLINICAL MICROBIOLOGY, Oct. 1990, p. 2279-2284 0095-1137/90/102279-06$02.00/0 Copyright 1990, American Society for Microbiology Vol. 28, No. 10 Importance of Rotavirus and Adenovirus Types 40
More informationIsolation and Characterization of an Equine Rotavirus
JOURNAL OF CLINICAL MICROBIOLOGY, Sept. 1983, p. 585-591 0095-1137/83/090585-07$02.OO/O Copyright C 1983, American Society for Microbiology Vol. 18, No. 3 Isolation and Characterization of an Equine Rotavirus
More informationRespiratory Syncytial Virus: Implications for Parenteral
INFECTION AND IMMUNITY, July 1982, p. 160-165 0019-9567/82/070160-06$02.00/0 Vol. 37, No. 1 Comparison of Enzyme-Linked Immunosorbent Assay and Neutralization Techniques for Measurement of Antibody to
More informationYellow Fever Vaccine: Direct Challenge of Monkeys Given Graded Doses of 17D
AppuzD MmcoaioLOGy, Apr. 1973, p. 539-544. Copyright i 1973 American Society for Microbiology Vol. 25, No. 4 Printed in U.SA. Yellow Fever Vaccine: Direct Challenge of Monkeys Given Graded Doses of 17D
More informationAnnex 3 Recommendations for the production and control of group C meningococcal conjugate vaccines (Addendum 2003)
World Health Organization WHO Technical Report Series, No. 926, 2004 Annex 3 Recommendations for the production and control of group C meningococcal conjugate vaccines (Addendum 2003) At its fifty-second
More informationDengue Infection at Children's Hospital of Bangkok
Dengue Infection at Children's Hospital of Bangkok Principal Investigators : Robert McNair Scott, MAJ, MC Suchitra Nimmannitya, M.D.1 Pethai Mansuwan, M.D.1 Franklin H. Top, Jr., LTC, MC William H. Bancroft,
More informationProduction of Interferon Alpha by Dengue Virus-infected Human Monocytes
J. gen. Virol. (1988), 69, 445-449. Printed in Great Britain 445 Key words: IFN-ct/dengue virus/monocytes Production of Interferon Alpha by Dengue Virus-infected Human Monocytes By ICHIRO KURANE AND FRANCIS
More informationneutralizing monoclonal antibodies and a corresponding set of escape mutants (6, 25, 26, 37, 38). In VP4, eight neutralization
JOURNAL OF VROLOGY, Mar. 1991, p. 1383-1391 0022-538X/91/031383-09$02.00/0 Copyright 1991, American Society for Microbiology Vol. 65, No. 3 The Amino-Terminal Half of Rotavirus SA114fM VP4 Protein Contains
More informationCoronaviruses cause acute, mild upper respiratory infection (common cold).
Coronaviruses David A. J. Tyrrell Steven H. Myint GENERAL CONCEPTS Clinical Presentation Coronaviruses cause acute, mild upper respiratory infection (common cold). Structure Spherical or pleomorphic enveloped
More informationRecombinant Virus Vaccine for Bluetongue Disease in Sheep
JOURNAL OF VIROLOGY, May 1990, p. 1998-2003 Vol. 64, No. 5 0022-538X/90/051998-06$02.00/0 Copyright 1990, American Society for Microbiology Recombinant Virus Vaccine for Bluetongue Disease in Sheep P.
More information3. Lymphocyte proliferation (fig. 15.4): Clones of responder cells and memory cells are derived from B cells and T cells.
Chapter 15 Adaptive, Specific Immunity and Immunization* *Lecture notes are to be used as a study guide only and do not represent the comprehensive information you will need to know for the exams. Specific
More informationIntestinal Trypsin Can Significantly Modify Antigenic Properties of Polioviruses: Implications for the Use of Inactivated Poliovirus Vaccine
JOURNAL OF VIROLOGY, Dec. 1987, p. 3749-3753 22-538X/87/123749-5$2./ Copyright C 1987, American Society for Microbiology Vol. 61, No. 12 Intestinal Trypsin Can Significantly Modify Antigenic Properties
More informationPrinciples of Vaccination
Immunology and Vaccine-Preventable Diseases Immunology is a complicated subject, and a detailed discussion of it is beyond the scope of this text. However, an understanding of the basic function of the
More informationDevelopment of live attenuated pediatric RSV vaccines
Development of live attenuated pediatric RSV vaccines Laboratory of Infectious Diseases, NIAID, NIH (Ursula Buchholz, Peter Collins) Center for Immunization Research, JHU (Ruth Karron) Infant with RSV
More informationEnzyme-Linked Immunosorbent Assay Compared with Neutralization Tests for Evaluation of Live Mumps Vaccines
JOURNAL OF CLINICAL MICROBIOLOGY, Jan. 1984, p. 21-25 95-1137/84/121-5$2./ Copyright C) 1984, American Society for Microbiology Vol. 19, No. 1 Enzyme-Linked Immunosorbent Assay Compared with Neutralization
More informationRotavirus Virus-Like Particles Administered Mucosally Induce Protective Immunity
JOURNAL OF VIROLOGY, Nov. 1997, p. 8707 8717 Vol. 71, No. 11 0022-538X/97/$04.00 0 Copyright 1997, American Society for Microbiology Rotavirus Virus-Like Particles Administered Mucosally Induce Protective
More informationhemagglutinin and the neuraminidase genes (RNA/recombinant viruses/polyacrylamide gel electrophoresis/genetics)
Proc. Natl. Acad. Sci. USA Vol. 73, No. 6, pp. 242-246, June 976 Microbiology Mapping of the influenza virus genome: Identification of the hemagglutinin and the neuraminidase genes (RNA/recombinant viruses/polyacrylamide
More information9/10/2018. Principles of Vaccination. Immunity. Antigen. September 2018
Centers for Disease Control and Prevention National Center for Immunization and Respiratory Diseases Principles of Vaccination September 2018 Chapter 1 September 2018 Photographs and images included in
More informationDengue: The next vaccine preventable disease? Prof John McBride James Cook University
Dengue: The next vaccine preventable disease? Prof John McBride James Cook University Dengue viruses A flavivirus ~11kb genome, ~50nm diameter, lipid envelope. Gene order 5 C-prM-E-NS1 Four serotypes (1-4)
More informationEfficacy of the pentavalent rotavirus vaccine, RotaTeq, in Finnish infants up to 3 years of age: the Finnish Extension Study
Eur J Pediatr (2010) 169:1379 1386 DOI 10.1007/s00431-010-1242-3 ORIGINAL PAPER Efficacy of the pentavalent rotavirus vaccine, RotaTeq, in Finnish infants up to 3 years of age: the Finnish Extension Study
More informationGastroenteritis and viral infections
Gastroenteritis and viral infections A Large number of viruses are found in the human gut; these include some that are associated with gastroenteritis Rotaviruses Adenoviruses 40/41 Caliciviruses Norwalk-like
More informationHaemophilus influenzae type B and Hib Vaccine Chapter 9
Haemophilus influenzae type B and Hib Vaccine Chapter 9 Haemophilus influenzae Aerobic gram-negative bacteria Polysaccharide capsule Six different serotypes (a-f) of polysaccharide capsule 95% of invasive
More informationROTAVIRUS VACCINES. Virology
ROTAVIRUS VACCINES Virology Rotavirus is a triple-layers viral particle belonging to the Reoviridae family. It contains 11 segments of double-stranded RNA, of which 6 are structural and 5 are non-structural
More informationThird line of Defense
Chapter 15 Specific Immunity and Immunization Topics -3 rd of Defense - B cells - T cells - Specific Immunities Third line of Defense Specific immunity is a complex interaction of immune cells (leukocytes)
More informationIsolation of Rhinovirus Intertypes Related to Either Rhinoviruses 12 and 78 or 36 and 58
INFECTION AND IMMUNITY, Apr. 1983, p. 213-218 0019-9567/83/040213-06$02.00/0 Copyright 1983, American Society for Microbiology Isolation of Rhinovirus Intertypes Related to Either Rhinoviruses 12 and 78
More informationEfficiency of Human Rotavirus Propagation in Cell Culture
JOURNAL OF CLINICAL MICROBIOLOGY, June 1984, p. 748-753 0095-1137/84/060748-06$02.00/0 Copyright 1984, American Society for Microbiology Vol. 19, No. 6 Efficiency of Human Rotavirus Propagation in Cell
More informationCan we improve the performance of live oral rotavirus vaccines?
Can we improve the performance of live oral rotavirus vaccines? Duncan Steele 9 th International Rotavirus Symposium 2 & 3 August 2010, Johannesburg, South Africa Vaccine efficacy against severe rotavirus
More informationIdentification of mutations in the rotavirus protein VP4 that alter sialic-acid-dependent infection
Journal of General Virology (1998), 79, 725 729. Printed in Great Britain.... SHORT COMMUNICATION Identification of mutations in the rotavirus protein VP4 that alter sialic-acid-dependent infection Juan
More information10th International Rotavirus Symposium Bangkok, Thailand
Rotavirus Host Range Restriction and Innate Immunity: Mechanisms of Vaccine Attenuation Harry Greenberg MD Stanford University 10th International Rotavirus Symposium Bangkok, Thailand 09/19/12 B dsrna
More informationMolecular Biology of Rotaviruses I. Characterization of Basic Growth Parameters and Pattern of
JOURNAL OF VIROLOGY, Aug. 1981, p. 490-496 Vol. 39, No. 2 0022-538X/81/080490-07$02.00/0 Molecular Biology of Rotaviruses I. Characterization of Basic Growth Parameters and Pattern of Macromolecular Synthesis
More informationPersistent Infection of MDCK Cells by Influenza C Virus: Initiation and Characterization
J. gen. Virol. (199), 70, 341-345. Printed in Great Britain 341 Key words: influenza C virus/interferon/persistent infection Persistent Infection of MDCK Cells by Influenza C Virus: Initiation and Characterization
More informationPolymerase Chain Reaction
JOURNAL OF CLINICAL MICROBIOLOGY, June 1992, P. 1365-1373 0095-1137/92/061365-09$02.00/0 Copyright X 1992, American Society for Microbiology Vol. 30, No. 6 Identification of Group A Rotavirus Gene 4 Types
More informationDengue-2 Vaccine: Viremia and Immune Responses in Rhesus Monkeys
INFECTION AND IMMUNITY, Jan. 1980, p. 181-186 0019-9567/80/01-0181/06$02.00/0 Vol. 27, No. 1 Dengue-2 Vaccine: Viremia and Immune Responses in Rhesus Monkeys ROBERT McN. SCOTT,'t* ANANDA NISALAK,' KENNETH
More informationSV40 Detection and Transmission: Does SV40 Circulate in Human Communities?
SV40 Detection and Transmission: Does SV40 Circulate in Human Communities? Keerti Shah, Dana Rollison and Raphael Viscidi Johns Hopkins Medical Institutions Baltimore, MD Background A large number of cancer
More informationIsolation of an Avianlike Group A Rotavirus from a Calf with Diarrhea
JOURNAL OF CLINICAL MICROBIOLOGY, Jan. 1992, p. 67-73 Vol. 30, No. 1 0095-1137/92/010067-07$02.00/0 Copyright C) 1992, American Society for Microbiology Isolation of an Avianlike Group A Rotavirus from
More informationRadioimmunoassay of Herpes Simplex Virus Antibody: Correlation with Ganglionic Infection
J. gen. Virol. (I977), 3 6, ~ 371-375 Printed in Great Britain 371 Radioimmunoassay of Herpes Simplex Virus Antibody: Correlation with Ganglionic Infection By B. FORGHANI, TONI KLASSEN AND J. R. BARINGER
More informationTitle Human Group A Rotavirus with Oligon. Citation 熱帯医学 Tropical medicine 35(3). p119-
NAOSITE: Nagasaki University's Ac Title Author(s) Determination of Single Hybridizati Human Group A Rotavirus with Oligon Ali, Ayub; Bingnan, Fu; Unicomb, Le Citation 熱帯医学 Tropical medicine 35(3). p119-
More informationROTAVIRUS VACCINES FOR AUSTRALIAN CHILDREN: INFORMATION FOR GPS AND IMMUNISATION PROVIDERS
ROTAVIRUS VACCINES FOR AUSTRALIAN CHILDREN: INFORMATION FOR GPS AND IMMUNISATION PROVIDERS Summary Rotavirus is the most common cause of severe gastroenteritis in infants and young children, accounting
More informationAlternative Rotavirus Vaccine Candidates: Why should we bother?
Alternative Rotavirus Vaccine Candidates: Why should we bother? Duncan Steele Initiative for Vaccine Research, WHO 7 th International Rotavirus Symposium 12-13 June 2006, Lisboa, Portugal Rotavirus Vaccines
More information